• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Novo Nordisk A/S (NVO)

    -NYSE
    43.81 Down 0.59(1.33%) Dec 19, 4:06PM EST
    Add to Portfolio
    Prev Close:44.40
    Open:43.54
    Bid:43.26 x 200
    Ask:45.99 x 1000
    1y Target Est:49.83
    Beta:0.93
    Next Earnings Date:N/A
    Day's Range:43.46 - 44.02
    52wk Range:35.76 - 49.11
    Volume:2,539,281
    Avg Vol (3m):1,514,810
    Market Cap:114.51B
    P/E (ttm):26.76
    EPS (ttm):1.64
    Div & Yield:0.61 (1.30%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVODown 1.33%114.51B
    LLYDown 0.07%77.44B
    PFEDown 0.09%201.24B
    SNYDown 0.90%121.74B

    Key Statistics

    Forward P/E (1 yr):22.47
    P/S (ttm):8.11
    Ex-Dividend Date:21-Mar-14

    Analysts

    Annual EPS Est (Dec-14) :1.70
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):2.07

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback